Related Experiment Video
Updated: Jan 20, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
Published on: March 20, 2020
High A20 expression negatively impacts survival in patients with breast cancer
Chang Ik Yoon1, Sung Gwe Ahn2, Soong June Bae2
1Department of Surgery, St Mary's Hospital, Catholic University College of Medicine, Seoul, Korea.
Background:
A20 protein has ubiquitin-editing activities and acts as a key regulator of inflammation and immunity. Previously, our group showed that A20 promotes tumor metastasis through multi-monoubiquitylation of SNAIL1 in basal-like breast cancer. Here, we investigated survival outcomes in patients with breast cancer according to A20 expression.
Patients And Methods:
We retrospectively collected tumor samples from patients with breast cancer. Immunohistochemistry (IHC) with an A20-specific antibody was performed, and survival outcomes were analyzed.
Results:
A20 expression was evaluated in 442 patients. High A20 expression was associated with advanced anatomical stage and young age. High A20 expression showed significantly inferior recurrence-free-survival and overall-survival (P<0.001 and P<0.001, respectively). Multivariate analysis showed that A20 was an independent prognostic marker for RFS (HRs: 2.324, 95% CIs: 1.446-3.736) and OS (HRs: 2.629, 95% CIs: 1.585-4.361). In human epidermal growth factor receptor 2 (HER2)-positive and triple negative breast cancer (TNBC) subtypes, high A20 levels were associated with poor OS.
Conclusion:
We found that A20 expression is a poor prognostic marker in breast cancer. The prognostic impact of A20 was pronounced in aggressive tumors, such as HER2-positive and TNBC subtypes. Our findings suggested that A20 may be a valuable target in patients with aggressive breast cancer.
Insights
High A20 protein expression indicates poor survival outcomes in breast cancer patients, particularly those with aggressive subtypes like HER2-positive and triple-negative breast cancer (TNBC). This suggests A20 may be a potential therapeutic target for aggressive breast cancer.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- A20 protein regulates inflammation and immunity through ubiquitin-editing activities.
- Previous research linked A20 to tumor metastasis in basal-like breast cancer via SNAIL1 modification.
- This study examines the prognostic significance of A20 expression in diverse breast cancer patient cohorts.
Purpose of the Study:
- To investigate the association between A20 protein expression levels and patient survival outcomes in breast cancer.
- To determine if A20 expression serves as an independent prognostic marker for recurrence-free survival (RFS) and overall survival (OS).
- To evaluate the prognostic impact of A20 in specific aggressive breast cancer subtypes, including HER2-positive and triple-negative breast cancer (TNBC).
Main Methods:
- Retrospective analysis of tumor samples from 442 breast cancer patients.
- Immunohistochemistry (IHC) using an A20-specific antibody to assess protein expression.
- Statistical analysis of survival data, including recurrence-free survival (RFS) and overall survival (OS), with multivariate analysis.
Main Results:
- High A20 expression correlated with advanced disease stage and younger patient age.
- Significantly inferior RFS and OS were observed in patients with high A20 expression (P<0.001 for both).
- A20 was identified as an independent prognostic marker for RFS (HR=2.324) and OS (HR=2.629).
- High A20 levels were associated with poorer OS in HER2-positive and TNBC subtypes.
Conclusions:
- A20 protein expression is a significant poor prognostic marker in breast cancer.
- The negative prognostic impact of A20 is particularly pronounced in aggressive subtypes like HER2-positive and TNBC.
- A20 represents a potential therapeutic target for patients diagnosed with aggressive forms of breast cancer.
More Related Videos
Related Concept Videos
Cancer Survival Analysis
Survival Tree
Building a Survival Tree
Constructing a...
Survival Curves
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
Impact of Groups on Groups
Negative Regulator Molecules
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time...

